Skip to main content

Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) in a Pediatric Population

Basic Details
Date Posted
Thursday, August 22, 2019
Status
Complete
Medical Product
angiotensin receptor blocker
angiotensin-converting enzyme (ACE) inhibitor
Description

The goal of this request was to estimate the number of prevalent users and dispensings of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) among pediatric populations in the Sentinel Distributed Database (SDD). Data from January 1, 2001 to December 31, 2012 from 15 Data Partners contributing to the SDD were included in this report. This request was distributed on July 1, 2016.

Deliverables (1)
Sentinel Modular Program Report: Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) in a Pediatric Population
Additional Details
FDA Center
CDER
Time Period
January 1, 2001 - December 31, 2012
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Population / Cohort
Children 1 to 72 months of age
Data Sources
Sentinel Distributed Database (SDD)